These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram. Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G; Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490 [TBL] [Abstract][Full Text] [Related]
9. CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials. Ueland T; Nymo SH; Latini R; McMurray JJ; Kjekshus J; Yndestad A; Fucili A; Grosu A; Masson S; Maggioni AP; Gullestad L; Aukrust P; ; Eur J Heart Fail; 2013 Jul; 15(7):747-55. PubMed ID: 23487539 [TBL] [Abstract][Full Text] [Related]
10. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ; Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure. Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996 [TBL] [Abstract][Full Text] [Related]
13. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial. Marchioli R; Levantesi G; Silletta MG; Barlera S; Bernardinangeli M; Carbonieri E; Cosmi F; Franzosi MG; Latini R; Lucci D; Maggioni AP; Moretti L; Nicolosi GL; Porcu M; Rossi MG; Tognoni G; Tavazzi L; Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):735-48. PubMed ID: 19589110 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. Ueland T; Jemtland R; Godang K; Kjekshus J; Hognestad A; Omland T; Squire IB; Gullestad L; Bollerslev J; Dickstein K; Aukrust P J Am Coll Cardiol; 2004 Nov; 44(10):1970-6. PubMed ID: 15542278 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP; J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559 [TBL] [Abstract][Full Text] [Related]
16. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Aukrust P Am Heart J; 2012 Dec; 164(6):878-83. PubMed ID: 23194488 [TBL] [Abstract][Full Text] [Related]
17. Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Disertori M; Lombardi F; Barlera S; Latini R; Maggioni AP; Zeni P; Di Pasquale G; Cosmi F; Franzosi MG; Am Heart J; 2010 May; 159(5):857-63. PubMed ID: 20435196 [TBL] [Abstract][Full Text] [Related]